- Report
- November 2023
- 81 Pages
France
From €3092EUR$3,500USD£2,696GBP
- Report
- October 2023
- 70 Pages
Egypt
From €3092EUR$3,500USD£2,696GBP
- Report
- February 2023
- 79 Pages
Saudi Arabia
From €3092EUR$3,500USD£2,696GBP
- Report
- January 2025
- 80 Pages
Vietnam
From €3092EUR$3,500USD£2,696GBP
- Report
- December 2024
- 85 Pages
India
From €3092EUR$3,500USD£2,696GBP
- Report
- February 2024
- 185 Pages
Global
From €3976EUR$4,500USD£3,467GBP
- Report
- July 2024
- 109 Pages
Global
From €4196EUR$4,750USD£3,659GBP
- Report
- February 2024
- 130 Pages
Global
From €4196EUR$4,750USD£3,659GBP
- Report
- January 2025
- 128 Pages
Global
From €3533EUR$3,999USD£3,081GBP
- Report
- May 2024
- 200 Pages
Global
From €3666EUR$4,150USD£3,197GBP
- Report
- March 2024
- 200 Pages
Global
From €3666EUR$4,150USD£3,197GBP
- Report
- August 2023
- 145 Pages
Global
From €2783EUR$3,150USD£2,427GBP
- Report
- July 2024
- 100 Pages
Global
From €3313EUR$3,750USD£2,889GBP
- Report
- July 2024
- 100 Pages
Global
From €3313EUR$3,750USD£2,889GBP
- Report
- February 2024
- 190 Pages
Global
From €4196EUR$4,750USD£3,659GBP
- Report
- February 2024
- 70 Pages
Australia
From €4196EUR$4,750USD£3,659GBP
- Report
- February 2024
- 110 Pages
Global
From €4196EUR$4,750USD£3,659GBP
- Report
- April 2023
- 81 Pages
Sweden
From €4196EUR$4,750USD£3,659GBP
- Report
- April 2023
- 70 Pages
Spain
From €4196EUR$4,750USD£3,659GBP
- Report
- April 2023
- 65 Pages
India
From €4196EUR$4,750USD£3,659GBP

Inhalers and nebulisers are medical devices used to deliver medication to the lungs. Inhalers are handheld devices that deliver medication in the form of a mist or aerosol, while nebulisers are larger machines that deliver medication in the form of a fine mist. Inhalers are the most common form of medication delivery for respiratory conditions such as asthma and COPD.
Inhalers and nebulisers are used by millions of people around the world, and the market for these devices is highly competitive. Companies in the market are constantly innovating to develop new and improved devices that are more effective and easier to use. Many of these devices are now available over the counter, making them more accessible to patients.
The inhaler market is also highly regulated, with governments and health authorities setting standards for the safety and efficacy of these devices. Companies must adhere to these standards in order to remain competitive.
Some of the major companies in the inhaler market include GlaxoSmithKline, Boehringer Ingelheim, AstraZeneca, Novartis, Merck, and Teva Pharmaceuticals. Show Less Read more